Candriam S.C.A. Increases Holdings in Xylem Inc. (NYSE:XYL)

Candriam S.C.A. lifted its position in Xylem Inc. (NYSE:XYL) by 10.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 304,162 shares of the industrial products company’s stock after acquiring an additional 28,999 shares during the quarter. Candriam S.C.A. owned 0.13% of Xylem worth $41,252,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its holdings in Xylem by 1,503.7% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after acquiring an additional 1,547,043 shares during the period. Duality Advisers LP purchased a new position in Xylem during the first quarter worth approximately $6,746,000. Vanguard Group Inc. grew its holdings in shares of Xylem by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock valued at $3,207,683,000 after purchasing an additional 187,847 shares during the period. Russell Investments Group Ltd. raised its position in shares of Xylem by 12.9% during the 1st quarter. Russell Investments Group Ltd. now owns 338,315 shares of the industrial products company’s stock valued at $43,737,000 after buying an additional 38,603 shares during the period. Finally, California State Teachers Retirement System increased its position in shares of Xylem by 1.4% during the 1st quarter. California State Teachers Retirement System now owns 393,856 shares of the industrial products company’s stock worth $50,902,000 after purchasing an additional 5,477 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 1.0 %

Shares of XYL stock opened at $126.81 on Friday. The company has a market capitalization of $30.80 billion, a P/E ratio of 45.13, a P/E/G ratio of 2.27 and a beta of 1.04. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $146.08. The company has a quick ratio of 1.33, a current ratio of 1.85 and a debt-to-equity ratio of 0.19. The firm has a 50-day moving average price of $134.13 and a 200 day moving average price of $133.70.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The firm had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company’s revenue was up 26.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.98 EPS. Research analysts forecast that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Thursday, August 29th. Xylem’s dividend payout ratio (DPR) is presently 51.25%.

Analyst Ratings Changes

XYL has been the topic of a number of research reports. Robert W. Baird increased their target price on shares of Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. TD Cowen restated a “hold” rating and set a $138.00 price objective on shares of Xylem in a research report on Tuesday. Oppenheimer raised their price target on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Royal Bank of Canada lifted their price objective on shares of Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Finally, UBS Group started coverage on Xylem in a report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price target for the company. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and a consensus price target of $147.54.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the transaction, the chief accounting officer now owns 3,536 shares in the company, valued at $490,195.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.